Relationship Between Cigarette Smoking and Other Coronary Risk Factors in Atherosclerosis: Risk of Cardiovascular Disease and Preventive Measures
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2417-2423
Author(s):
Aurelio Leone
Oligonucleotide-Based Molecular Therapy for Restenosis after Angioplasty
Journal:
Current Drug Targets
Volume:
4
Page:
613-618
Author(s):
Motokuni Aoki, Ryuichi Morishita and Toshio Ogihara
Aldose Reductase: A Novel Target for Cardioprotective Interventions
Journal:
Current Drug Targets
Volume:
4
Page:
625-632
Author(s):
Ravichandran Ramasamy
Proteasomes as Drug Targets
Journal:
Current Drug Targets
Volume:
4
Page:
656-670
Author(s):
Marco Piccinini, Michael Mostert and Maria Teresa Rinaudo
Preface [Hot topic: Modulation of Heme Oxygenase-1 as a Therapeutic Target (Executive Editor : M.J. Alcaraz)]
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
i-i
Author(s):
M. J. Alcaraz
Role of Heme Oxygenase-1 in Cardiovascular Function
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2479-2487
Author(s):
Mark A. Perrella and Shaw-Fang Yet
Heme Oxygenase-1 against Vascular Insufficiency: Roles of Atherosclerotic Disorders
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2489-2497
Author(s):
Kazunobu Ishikawa
Transcriptional Regulation of the Heme Oxygenase-1 Gene Via the Stress Response Element Pathway
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2499-2511
Author(s):
J. Alam and J. L. Cook
Therapeutic Applications of Human Heme Oxygenase Gene Transfer and Gene Therapy
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2513-2524
Author(s):
Nader G. Abraham
Bioactivity and Pharmacological Actions of Carbon Monoxide-Releasing Molecules
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2525-2539
Author(s):
Roberto Motterlini, Brian E. Mann, Tony R. Johnson, James E. Clark, Roberta Foresti and Colin J. Green